Učitavanje...
Transcatheter aortic valve replacement in low-risk patients: superiority or shifting goalposts and statistical crystal-gazing?
Transcatheter aortic valve replacement (TAVR) has been compared to surgical aortic valve replacement (SAVR) in two different industry-sponsored trials (Edwards Lifesciences—the SAPIEN 3 system; Medtronic—the CoreValve, EvolutR, and EvolutPRO) in patients with low risk for surgical aortic valve repla...
Spremljeno u:
| Izdano u: | Indian J Thorac Cardiovasc Surg |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Singapore
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7525926/ https://ncbi.nlm.nih.gov/pubmed/33061061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12055-019-00835-w |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|